1-(4-FORMYLPHENYL)-1-OXO-5,8,11,14-TETRAOXA-2-AZAHEPTADECAN-17-OIC ACID, 95%, 500mg

3-Bromo-2-chlorobenzoic acid, 95.0%, 10g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid, 97%, 1g

(R)-1-(4-(Trifluoromethoxy)phenyl)ethanamine, 95.0%, 1g

2,5-Norbornadiene, 98.0%, 10g

5-Methylhexanoic Acid>98.0%(T)(GC)25mL

(S)-3-(5-bromo-1H-indol-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 500mg

alpha,alpha,alpha'-Tris(4-hydroxyphenyl)-1-ethyl-4-isopropylbenzene>98.0%(GC)25g

methyl (S)-cyclohex-3-ene-1-carboxylate, 98%, 25g

4-(Prop-1-yn-1-yl)benzoic acid, 97.0%, 250mg

2-{3-oxo-2h,3h-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetonitrile, 95%, 10g

5-Bromo-2-methylphenol, 98.0%, 1g

4-(4-Fluoro-phenyl)-pyrimidin-2-ylamine, 95.0%, 1g